If you are positive for COVID-19 and meet the criteria listed below, you may be a candidate for monoclonal antibody medication.
Monoclonal antibody medication may help decrease the risk of severe illness and complications due to COVID-19, and is most effective if received early in the onset of the infection. Choosing to get monoclonal antibody treatment should be based on risk factors and not on current symptoms or waiting to see what symptoms develop.
Upon receiving positive COVID-19 test results, call Winneshiek Medical Center at 563-382-2911 and ask for an appointment in the Respiratory Illness Clinic to discuss your options with a health care provider.
Please bring documentation of your COVID-19 test result with you to the appointment. Patients treated with this medication should continue to self-isolate and use infection control measures, according to CDC guidelines.
Monoclonal antibody medication criteria includes: COVID-19 positive test results; a 10-day time period of symptom onset; mild or moderate case; patient older than age 12 and weighing more than 88 lbs.; at high risk* for progression to severe COVID-19 symptoms and/or hospitalization.
*High risk is defined as patients who meet at least one of the following criteria: have a body mass index (BMI) greater than 35; chronic kidney disease; diabetes; immunosuppressive disease; currently receiving immunosuppressive treatment; are over 65 years of age; are over 55 years of age and have cardiovascular disease, hypertension or chronic obstructive pulmonary disease/other chronic respiratory disease; are 12-17 years of age and have BMI greater than the 85th percentile for age and gender based on CDC growth charts, https://www.cdc.gov/growthcharts/clinical_charts.htm; sickle cell disease; congenital or acquired heart disease; neurodevelopmental disorders; medical-related technological dependence; asthma, reactive airway or other chronic respiratory disease that requires daily medication for control.